References
- Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Protein Fold Disord 2003;10:160–184.
- Benson MD, Kincaid JC. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007;36:411–423.
- Hattori T, Takei Y, Koyama J, Nakazato M, Ikeda S. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy. Amyloid: J Protein Fold Disord 2003;10:229–239.
- Suhr OB, Lindqvist P, Olofsson BO, Waldenstrom A, Backman C. Myocardial hypertrophy and function are related to age at onset in familial amyloidotic polyneuropathy. Amyloid: J Protein Fold Disord 2006;13:154–159.
- Andersson R. Familial amyloidosis with polyneuropathy. A clinical study based on patients living in northern Sweden. Acta Med Scand Suppl 1976;590:1–64.
- Holmgren G, Costa PM, Andersson C, Asplund K, Steen L, Beckman L, Nylander PO, Teixeira A, Saraiva MJ, Costa PP. Geographical distribution of TTR met30 carriers in northern Sweden: discrepancy between carrier frequency and prevalence rate. J Med Genet 1994;31:351–354.
- Holmgren G, Hellman U, Anan I, Lundgren HE, Jonasson J, Stafberg C, Fahoum S, Suhr OB. Cardiomyopathy in Swedish patients with the Gly53Glu and His88Arg transthyretin variants. Amyloid: J Protein Fold Disord 2005;12:184–188.
- Janunger T, Anan I, Holmgren G, Lovheim O, Ohlsson PI, Suhr OB, Tashima K. Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser. Amyloid: Int J Exp Clin Invest 2000;7:137–140.
- Blevins G, Macaulay R, Harder S, Fladeland D, Yamashita T, Yazaki M, Hamidi Asl K, Benson MD, Donat JR. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His. Neurology 2003;60:1625–1630.
- Morner S, Hellman U, Suhr OB, Kazzam E, Waldenstrom A. Amyloid heart disease mimicking hypertrophic cardiomyopathy. J Intern Med 2005;258:225–230.
- Utsugisawa K, Tohgi H, Nagane Y, Yamagata M, Saito K, Mihara M. Familial amyloid polyneuropathy related to transthyretin mutation Val30 to Leu in a Japanese family. Muscle Nerve 1998;21:1783–1785.
- Nakazato M, Ikeda S, Shiomi K, Matsukura S, Yoshida K, Shimizu H, Atsumi T, Kangawa K, Matsuo H. Identification of a novel transthyretin variant (Val30—-Leu) associated with familial amyloidotic polyneuropathy. FEBS Lett 1992;306:206–208.
- Yazaki M, Varga J, Dyck PJ, Benson MD. A new transthyretin variant Leu55Gln in a patient with systemic amyloidosis. Amyloid: J Protein Fold Disord 2002;9:268–271.
- Zeldenrust SR, Skinner M, Skare J, Benson MD. A new transthretin variant (His 69) associated with vitreous amyloid a FAP family. Amyloid: Int J Exp Clin Invest 1994;1:17–22.
- Ando Y, Terazaki H, Nakamura M, Ando E, Haraoka K, Yamashita T, Ueda M, Okabe H, Sasaki Y, Tanihara H, Uchino M, Inomata Y. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation. Transplantation 2004;77:345–349.
- Yamashita T, Ando Y, Ueda M, Nakamura M, Okamoto S, Zeledon ME, Hirahara T, Hirai T, Ueda A, Misumi Y, Obayashi K, Inomata H, Uchino M. Effect of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. Neurology 2008;70:123–128.
- Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, Negi A, Ando M. De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation [letter]. Transplantation 1996;62:1037–1038.